Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 3 |
iShares Silver Trust
SLV
|
+$1.03B |
| 4 |
Walmart Inc
WMT
|
+$862M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$850M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.99B |
| 2 |
Micron Technology
MU
|
+$1.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$772M |
| 4 |
Tesla
TSLA
|
+$700M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$639M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.77% |
| 2 | Healthcare | 1.08% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.94% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10576
CALL
Goldgroup Mining
GORO
$207M
| $35.8K | ﹤0.01% |
43,200
-6,500
| -13% | -$5.18K |
|
10577
Alpha Tau Medical Warrant
DRTSW
$87.6M
| $35.7K | ﹤0.01% |
104,929
-199
| -0.2% | -$67 |
|
10578
CALL
Stereotaxis
STXS
$138M
| $35.6K | ﹤0.01% |
+15,500
| New | +$41.3K |
|
10579
PUT
ProKidney
PROK
$278M
| $35.6K | ﹤0.01% |
15,900
+4,800
| +43% | +$12.6K |
|
|
VIVO
10580
PUT
VivoPower PLC
VIVO
$150M
| $35.6K | ﹤0.01% |
15,700
+1,800
| +13% | +$6.18K |
|
10581
CALL
Lantern Pharma
LTRN
$33.9M
| $35.5K | ﹤0.01% |
+11,700
| New | +$43.6K |
|
10582
CALL
Cato Corp
CATO
$67.9M
| $35.2K | ﹤0.01% |
11,400
-56,500
| -83% | -$208K |
|
|
VSA
10583
VisionSys AI
VSA
$9.27M
| $35.2K | ﹤0.01% |
+1,449
| New | +$957K |
|
10584
Mangoceuticals
MGRX
$9.17M
| $35.2K | ﹤0.01% |
+47,503
| New | +$77K |
|
|
ATYR
10585
PUT
aTyr Pharma
ATYR
$54.8M
| $35K | ﹤0.01% |
44,700
+32,500
| +266% | +$26.7K |
|
10586
PUT
Black Diamond Therapeutics
BDTX
$116M
| $35K | ﹤0.01% |
+14,400
| New | +$51K |
|
|
NXB
10587
NextBoat Inc
NXB
$50.5M
| $35K | ﹤0.01% |
+16,742
| New | +$49.5K |
|
10588
Arts-Way Manufacturing Co
ARTW
$16.2M
| $34.8K | ﹤0.01% |
14,802
-7,018
| -32% | -$17.2K |
|
10589
PUT
Maravai LifeSciences
MRVI
$849M
| $34.8K | ﹤0.01% |
+10,700
| New | +$36K |
|
|
HTZWW
10590
Hertz Global Holdings Warrants
HTZWW
$97.3M
| $34.7K | ﹤0.01% |
+12,964
| New | +$38.7K |
|
|
RUBI
10591
Rubico Inc
RUBI
$1.13M
| $34.6K | ﹤0.01% |
+17
| New | +$770K |
|
10592
HeartCore Enterprises
HTCR
$3.75M
| $34.5K | ﹤0.01% |
5,659
+2,611
| +86% | +$31.9K |
|
|
SUIG
10593
Sui Group Holdings
SUIG
$62M
| $34.4K | ﹤0.01% |
20,614
-201,408
| -91% | -$521K |
|
10594
Hydrofarm Holdings
HYFM
$7M
| $34.3K | ﹤0.01% |
+22,716
| New | +$51K |
|
|
LGO
10595
PUT
Largo
LGO
$74.1M
| $34.2K | ﹤0.01% |
+35,800
| New | +$42.5K |
|
|
GAUZ
10596
Gauzy
GAUZ
$7.81M
| $34K | ﹤0.01% |
+26,363
| New | +$99.3K |
|
10597
Bionano Genomics
BNGO
$13.9M
| $33.9K | ﹤0.01% |
+22,170
| New | +$38.4K |
|
10598
PUT
Rani Therapeutics
RANI
$89.5M
| $33.8K | ﹤0.01% |
+25,000
| New | +$37.7K |
|
10599
FibroBiologics
FBLG
$7.06M
| $33.7K | ﹤0.01% |
+7,488
| New | +$52.7K |
|
|
MAPS
10600
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $33.7K | ﹤0.01% |
40,800
+14,100
| +53% | +$13.9K |
|
Similar funds
Jane Street's Q4 2025 Portfolio in Review
As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
- Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
- Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
- Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
- Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
- Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.